EPA and DHA as markers of nutraceutical treatment response in major depressive disorder.

Kiki P van der BurgLachlan CribbJoseph FirthDiana KarmacoskaDavid MischoulonGerard J ByrneChad BousmanCon StoughJenifer MurphyGeorgina OliverMichael BerkChee H NgJerome Sarris

Published in: European journal of nutrition (2019)

Changes in fatty acid levels resulting from a nutraceutical combination containing EPA and DHA provide a response biomarker in treating depression.

Keyphrases

major depressive disorder
fatty acid
bipolar disorder
depressive symptoms
sleep quality
physical activity